Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

185.80p
   
  • Change Today:
    -0.80p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.34m
  • Volume: 203,266
  • Market Cap: £403.82m
  • RiskGrade: 156

Advanced Medical Solutions inks three hospital distribution deals

By Josh White

Date: Wednesday 25 Oct 2023

LONDON (ShareCast) - (Sharecast News) - Tissue-healing technology specialist Advanced Medical Solutions announced the execution of its new US 'LiquiBand' route-to-market strategy on Wednesday, signing three hospital distribution agreements.
The AIM-traded firm said the move was poised to drive the growth of LiquiBand in the United States from the fourth quarter of the year.

Each five-year agreement was structured to expedite market share expansion and capitalise on the existing momentum established by AMS and its partners in the $270m market segment.

The strategy was designed to facilitate enhanced product and brand differentiation, further solidifying its position, especially with the anticipated approval of the 'Connexicon' range in 2024.

Moreover, the board said the newly implemented route-to-market strategy had created a robust marketing platform, enabling the successful introduction of LiquiBand XL to the US market across all three distribution channels.

That move built on the product's current success, AMS said, contributing to an overall acceleration of LiquiBand growth.

AMS said the transition to the new agreements was seamless, with no disruption to end-user sales and no impact on customers.

Standard order patterns were also re-established for all three partners, ensuring reliable service in the critical healthcare sector.

"The successful signing of all three US distribution agreements is a significant step forward for the group and marks an important inflection point for the growth of the LiquiBand portfolio," said chief executive officer Chris Meredith.

"We are extremely proud of what we have achieved to date in the US, having secured over 20% of the available market."

That strengthened route-to-market strategy, Meredith said, now provided more significant opportunities for the company and was an essential step in its ambition to more-than-double market share in the medium term.

"I look forward to building even stronger and more productive relationships with all our partners as we embark on this next phase of the LiquiBand growth story."

At 0845 BST, Advanced Medical Solutions Group shares were up 2.59% at 194.1p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 185.80p
Change Today -0.80p
% Change -0.43 %
52 Week High 258.00
52 Week Low 177.20
Volume 203,266
Shares Issued 217.34m
Market Cap £403.82m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.09% below the market average71.09% below the market average71.09% below the market average71.09% below the market average71.09% below the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average
Price Trend
37.43% below the market average37.43% below the market average37.43% below the market average37.43% below the market average37.43% below the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average
Income
86.48% below the market average86.48% below the market average86.48% below the market average86.48% below the market average86.48% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
40.43% below the market average40.43% below the market average40.43% below the market average40.43% below the market average40.43% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 23,290 @ 185.80p
16:35 53 @ 185.80p
16:35 276 @ 185.80p
16:35 373 @ 185.80p
16:35 66 @ 185.80p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page